Management of drug resistance in the population: influenza as a case study

Area of Science:

• Mathematical modeling of infectious diseases
• Epidemiology and public health
• Antimicrobial resistance dynamics

Background:

• Drug resistance in pathogens is a significant treatment challenge, driven by genetic mutations.
• Within-host dynamics suggest immune response thresholds can limit resistance emergence during therapy.
• Population-level resistance involves complex within-host and between-host transmission mechanisms.

Purpose of the Study:

• To identify an effective population-level treatment strategy for managing drug resistance.
• To explore how host population dynamics influence the emergence and spread of resistant strains.
• To provide insights for mitigating infectious disease outbreaks caused by drug-resistant pathogens.

Main Methods:

• Development and application of a mathematical model to simulate infectious disease dynamics.
• Analysis of within-host and between-host infection mechanisms contributing to resistance.
• Case study simulations using influenza infection data to validate the model's predictions.

Main Results:

• In the absence of pre-existing immunity, reducing susceptible host populations before large-scale drug deployment can prevent resistant strain spread.
• Simulations indicate that initial prevalence of drug-sensitive strains under low drug pressure, followed by intensive treatment, is effective.
• This strategy minimizes overall infections and averts outbreaks of drug-resistant infections.

Conclusions:

• Population-level interventions, including host depletion and strategic treatment timing, are crucial for combating drug resistance.
• Mathematical modeling provides valuable tools for designing effective public health strategies against evolving pathogens.
• Findings offer a framework for managing infectious diseases and preventing the rise of antimicrobial resistance.